China (Mainland)
Treatment of Community-Acquired Pneumonia Moxifloxacin HCl CAS NO.186826-86-8
- Min.Order: 10 Gram
- Payment Terms: T/T,
- Product Details
Keywords
- Moxifloxacin Hydrochloride
- 186826-86-8 price
- 186826-86-8 factory
Quick Details
- ProName: Treatment of Community-Acquired Pneumo...
- CasNo: 186826-86-8
- Molecular Formula: C21H25ClFN3O4
- Appearance: Light yellow solid
- Application: Pharmaceutical raw intermediates
- DeliveryTime: Within 5 days after payment
- PackAge: as request
- Port: Wuhan / Shanghai / Guangzhou ...
- ProductionCapacity: 1000 Metric Ton/Month
- Purity: 99%
- Storage: dry, dark and ventilated place
- Transportation: EMS, HKEMS, DHL, TNT, UPS, Fedex...
- LimitNum: 10 Gram
Superiority
1. Hubei Jusheng Technology Co., Ltd., is a global chemical industry manufacturers and suppliers of pharmaceuticals and intermediates in China.
2. The yearly production capacity is 50000MT, 80% for export.We have a professinal export team. Both by Air and by Sea,we ensure that we meet the customer expectations with promptness.
3. Our company facing global High-tech pharmaceutical raw materials, high complex new type intermediates, fine chemicals custom synthesis, scale-up production and Rare chemicals trade. Corey have well-equipped machine, strong technical force and considerate marketing team service.
4. We also have rich experience advantage in basic research, small scale process development, scale-up, industrial technology development & production and cost control.
Details
Product Name: Moxifloxacin Hydrochloride
Synonyms: ACTIRA; AVALOX; BAY-12-8039; MOXIFLOXACIN HCl; MOXIFLOXACIN HYDROCHLORIDE; PROFLOX; MoxifloxacineHCl; Moxifloxacinehydrochloride; Moxiflaxacin HCl; ;
CAS No.: 186826-86-8
EINECS No.:
Molecular Formula: C21H25ClFN3O4
Molecular Weight: 437.89
Melting point:
Appearance: Light yellow solid
Standard: Enterprise Standard
Packing: 25KG/Drum or as per your requirements
Application: Applied to treatment of community-acquired pneumonia, Acute exacerbation of chronic bronchitis, acute sinusitis caused by staphylococcus aureus, Bacillus influenzae, pneumococcus, Mucositis bacteria Mora, pneumobacillus
Synonyms: ACTIRA; AVALOX; BAY-12-8039; MOXIFLOXACIN HCl; MOXIFLOXACIN HYDROCHLORIDE; PROFLOX; MoxifloxacineHCl; Moxifloxacinehydrochloride; Moxiflaxacin HCl; ;
CAS No.: 186826-86-8
EINECS No.:
Molecular Formula: C21H25ClFN3O4
Molecular Weight: 437.89
Melting point:
Appearance: Light yellow solid
Standard: Enterprise Standard
Packing: 25KG/Drum or as per your requirements
Application: Applied to treatment of community-acquired pneumonia, Acute exacerbation of chronic bronchitis, acute sinusitis caused by staphylococcus aureus, Bacillus influenzae, pneumococcus, Mucositis bacteria Mora, pneumobacillus
| Appearance | Light yellow or yellow powder | Light yellow poder | ||
| Appearance of Solution | Clear, ≤GY2 | Clear, GY2 | ||
|
Identification |
IR |
Corresponding to Reference Spectrum |
Complies | |
| Chloride | Positive | Positive | ||
| HPLC |
Corresponding to Reference Retention Time |
Complies | ||
| PH | 3.9 ~ 4.6 | 4.28 | ||
| Specific Optical Rotation | -125°~ -138° | -126.08° | ||
|
Related Substances |
Impurity A | ≤0.1% | 0.02% | |
| Impurity B | ≤0.1% | 0.04% | ||
| Impurity C | ≤0.1% | 0.03% | ||
| Impurity D | ≤0.1% | 0.04% | ||
| Impurity E | ≤0.1% | 0.03% | ||
| Total of Impurities | ≤0.3% | 0.24% | ||
| Water | ≤4.5% | 4.01% | ||
| Sulphated Ash | ≤0.1% | 0.06% | ||
| Assay | 98.0% ~ 102.0% | 99.20% | ||
| Conclusion | Comply with the EP6.0 & BP2008 | |||